# Marker Therapeutics, Inc.: filings

MRKR · Nasdaq · CIK 1094038 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrkr.md) · [Financials](/companies/mrkr/financials.md) · [Filings](/companies/mrkr/filings.md) · [Insiders](/companies/mrkr/insiders.md)

## Reports and events: 307 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 175, 4 139, 10-Q 53, 3 39, CORRESP 32, UPLOAD 27, 10-K 18, NT 10-Q 16, SC 13D/A 16, 424B3 15, SC 13G/A 15, EFFECT 13, DEF 14A 10, SC 13D 10, 10-Q/A 9, D 9, SC 13G 9, 424B5 8, S-3 8, DEFA14A 7, NT 10-K 7, 5 5, SCHEDULE 13D/A 5, 424B7 4, 8-K/A 4, ARS 4, POS AM 4, S-8 4, CT ORDER 3, PRE 14A 3, S-1 3, S-3/A 3, 10-K/A 2, DEF 14C 2, PRE 14C 2, S-1/A 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, 8-A12B 1, 8-A12B/A 1, CERTNAS 1, D/A 1, DEFM14A 1, DEFR14A 1, DEL AM 1, NTN 10K 1, PREM14A 1, PRER14A 1, RW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 11:12 ET | [8-K](/filings/0001104659-26-116720.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-116720 |
| 2026-08-14 | 20:35 ET | [10-Q](/filings/0001104659-26-097262.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097262 |
| 2026-05-15 | 21:00 ET | [10-Q](/filings/0001104659-26-062763.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062763 |
| 2026-05-04 | 20:30 ET | [8-K](/filings/0001104659-26-054940.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-054940 |
| 2026-03-20 | 20:05 ET | [DEF 14A](/filings/0001104659-26-032694.md) | Proxy statement, period 2026-05-01 | 0001104659-26-032694 |
| 2026-03-19 | 21:36 ET | [8-K](/filings/0001104659-26-031309.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-031309 |
| 2026-03-18 | 21:26 ET | [10-K](/filings/0001104659-26-031274.md) | Annual report, period 2025-12-31 | 0001104659-26-031274 |
| 2026-02-09 | 21:06 ET | [8-K](/filings/0001104659-26-012063.md) | 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001104659-26-012063 |
| 2025-11-17 | 21:22 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000858.md) | Ownership report, active investor, amended | 0001072613-25-000858 |
| 2025-11-14 | 12:20 ET | [8-K](/filings/0001104659-25-111940.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-111940 |
| 2025-11-13 | 22:29 ET | [10-Q](/filings/0001104659-25-111502.md) | Quarterly report, period 2025-09-30 | 0001104659-25-111502 |
| 2025-11-05 | 12:36 ET | [8-K](/filings/0001104659-25-106669.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-106669 |
| 2025-10-06 | 11:30 ET | [8-K](/filings/0001104659-25-096935.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-096935 |
| 2025-08-26 | 11:16 ET | [8-K](/filings/0001104659-25-082783.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-082783 |
| 2025-08-20 | 20:58 ET | [SCHEDULE 13D/A](/filings/0001104659-25-080957.md) | Ownership report, active investor, amended | 0001104659-25-080957 |
| 2025-08-19 | 18:42 ET | [SCHEDULE 13D/A](/filings/0001104659-25-080213.md) | Ownership report, active investor, amended | 0001104659-25-080213 |
| 2025-08-18 | 21:34 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000647.md) | Ownership report, active investor, amended | 0001072613-25-000647 |
| 2025-08-14 | 21:16 ET | [10-Q](/filings/0001410578-25-001826.md) | Quarterly report, period 2025-06-30 | 0001410578-25-001826 |
| 2025-08-12 | 20:08 ET | [8-K](/filings/0001104659-25-076834.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-25-076834 |
| 2025-06-17 | 12:00 ET | [8-K](/filings/0001104659-25-060092.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-060092 |
| 2025-06-09 | 20:13 ET | [8-K](/filings/0001104659-25-057836.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-057836 |
| 2025-05-20 | 12:32 ET | [8-K](/filings/0001104659-25-050771.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-050771 |
| 2025-05-15 | 21:00 ET | [10-Q](/filings/0001410578-25-001342.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001342 |
| 2025-04-24 | 20:42 ET | [DEF 14A](/filings/0001104659-25-038633.md) | Proxy statement, period 2025-06-06 | 0001104659-25-038633 |
| 2025-03-31 | 12:48 ET | [8-K](/filings/0001104659-25-029666.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-029666 |
| 2025-03-31 | 12:18 ET | [10-K](/filings/0001410578-25-000549.md) | Annual report, period 2024-12-31 | 0001410578-25-000549 |
| 2025-03-27 | 21:00 ET | [8-K](/filings/0001104659-25-028821.md) | 5.07 Shareholder vote results | 0001104659-25-028821 |
| 2025-03-04 | 22:08 ET | [8-K/A](/filings/0001104659-25-020405.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-25-020405 |
| 2025-02-19 | 22:02 ET | [8-K](/filings/0001104659-25-015224.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-25-015224 |
| 2025-02-04 | 21:05 ET | [DEF 14A](/filings/0001104659-25-009098.md) | Proxy statement, period 2025-03-21 | 0001104659-25-009098 |
| 2025-01-30 | 21:05 ET | [8-K](/filings/0001104659-25-007574.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-007574 |
| 2024-12-23 | 21:30 ET | [8-K](/filings/0001104659-24-131322.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-131322 |
| 2024-12-23 | 21:30 ET | [SCHEDULE 13D/A](/filings/0001072613-24-000928.md) | Ownership report, active investor, amended | 0001072613-24-000928 |
| 2024-12-19 | 13:21 ET | [8-K](/filings/0001104659-24-130002.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-130002 |
| 2024-12-17 | 12:10 ET | [8-K](/filings/0001104659-24-129181.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-129181 |
| 2024-11-14 | 21:45 ET | [8-K](/filings/0001104659-24-119077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-119077 |
| 2024-11-14 | 21:05 ET | [10-Q](/filings/0001410578-24-001978.md) | Quarterly report, period 2024-09-30 | 0001410578-24-001978 |
| 2024-08-14 | 20:47 ET | [8-K](/filings/0001104659-24-089704.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-089704 |
| 2024-08-14 | 20:39 ET | [10-Q](/filings/0001410578-24-001454.md) | Quarterly report, period 2024-06-30 | 0001410578-24-001454 |
| 2024-08-12 | 11:12 ET | [8-K](/filings/0001104659-24-088054.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-088054 |
| 2024-06-12 | 20:05 ET | [8-K](/filings/0001104659-24-070830.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-24-070830 |
| 2024-05-17 | 22:25 ET | [SC 13D/A](/filings/0001072613-24-000515.md) | Ownership report, active investor, amended | 0001072613-24-000515 |
| 2024-05-15 | 20:40 ET | [8-K](/filings/0001104659-24-062001.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-062001 |
| 2024-05-15 | 20:03 ET | [10-Q](/filings/0001410578-24-000865.md) | Quarterly report, period 2024-03-31 | 0001410578-24-000865 |
| 2024-04-26 | 20:05 ET | [DEF 14A](/filings/0001104659-24-052914.md) | Proxy statement, period 2024-06-06 | 0001104659-24-052914 |
| 2024-04-08 | 11:09 ET | [8-K](/filings/0001104659-24-044496.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-044496 |
| 2024-03-26 | 22:18 ET | [8-K](/filings/0001104659-24-038533.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-038533 |
| 2024-03-26 | 21:37 ET | [10-K](/filings/0001410578-24-000297.md) | Annual report, period 2023-12-31 | 0001410578-24-000297 |
| 2024-03-01 | 13:02 ET | [8-K](/filings/0001104659-24-029638.md) | 1.02 Termination of a material agreement | 0001104659-24-029638 |
| 2024-02-26 | 12:58 ET | [8-K](/filings/0001104659-24-027293.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-027293 |

Page 1 of 7. [Older](/companies/mrkr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.